Ministry of Foreign Affairs of Japan Medical Visa Guarantee Agency No. B-66
Fukuoka Prefecture, Japan Travel service No. 35
Japanese Registration Support Organization No. 19-000303
Japan Medical Equipment Sales and Leasing
Medical Supporter
Accompanied with heart, medical care support in Japan
Neoantigen Anticancer Vaccine Therapy
NEO Clinic Tokyo
◎ Treatment philosophy of NEO Clinic Tokyo
Cancer immunotherapy can be administered in conjunction with standard therapies such as chemotherapy, radiation, and surgery, and will combineNext Generation Sequencerandartificial intelligence (AI)rightin tumor tissueGenetics are analyzed to identify appropriate medications for each patient and to manage them and suggest potentially effective therapies, such as disease prevention recommendations and what to follow after standard treatment. The hospital will coordinate and provide comprehensive medical services in all aspects, including cancer rehabilitation combining nutrition therapy and exercise therapy, to provide comprehensive support for cancer patients.
Next-generation sequencer: Cells with genetic mutations can be found in tumor tissues, which is also known as the cause of cancer. Using the next-generation sequencer, artificial intelligence (AI) is used to perform gene sequencing and analysis, and find gene mutations for targeted drug treatment. This method has been published and promoted in mainstream overseas academic journals.
Artificial intelligence (AI) makes treatment strategies: Accumulate the experience and knowledge of experts and provide treatment suggestions based on Peng Da's information and intelligence analysis capabilities. In addition to the genomic information of cancer, the image analysis capabilities of AI can also be used to find gene mutations in pathological tissues, and to find out the appropriate treatment methods with drugs.
◎ Precise immunotherapy
Neoantigen Anticancer Vaccine Therapy: Carry out gene sequencing detection for tumor tissue or blood, find out tumor antigens and synthesize several new antigens, tailor-made antigen vaccines for the tumor patients and administer them, and then induce anti-tumor immune responses. There are abundant clinical researches and trials in Kyushu University and Todai Institute of Medical Sciences Hospital. (Hijikaya Yasuki et al, Clinical Immunology. 2016 V Hijikata Yasuki et al, PLoS one. 2018)
immunosuppressive therapy: Cancer patients have substances produced by cancer cells that suppress immunity and cannot have a normal immune response mechanism. Even treatments that can boost immunity will not work well, so anti-cancer vaccines are used in combination with a small amount of chemotherapy, antibody therapy, or targeted drugs that relieve immunosuppression. This combination is demonstrated by the doctors of the hospital in the clinical research of Ninth University and Dongda Medical Research Hospital, and has also been published in overseas academic journals.
immune activation therapy: Drugs rich in cytokines activate the immune system and improve immunity through injection or oral administration.
◎ Precise immunotherapy process
◎ Precise adjuvant therapy
Nutritional therapy: The nutritional metabolism of cancer cells and immune cells is related, and has a great relationship with cancer immunity and intestinal bacterial flora. The hospital has suggested nutritional supplements.
Exercise therapy: Studies have shown that muscle mass is positively related to cancer treatment. And long-term bed rest can cause low muscle endurance and stiffness. Special treatments and massages are offered here.
◎ Physician introduction
Daejeon Ted Physician
Koji Hijikata physician
2000
Graduated from the Faculty of Medicine, University of Tokyo
2000~2004
Graduate School of Medicine, The University of Tokyo
Get an MD
2004~2005
University of Tokyo Hospital
Assistant in human pathology and pathological diagnosis
2005~2013
Physician at Toranomon Hospital
2013~2018
The University of Tokyo Institute of Medical Sciences Affiliated Hospital
Associate Professor of Department of Pathology
incumbent
The University of Tokyo Institute of Medical Sciences Affiliated Hospital
Chief of Palliative Medicine and Oncology
Certification
General Internal Medicine Specialist, Japanese Society of Internal Medicine
Japanese Academy of Internal Medicine trainee physician instructor
Japanese Cancer Treatment Certified Physician
Regenerative Medicine Certified Physician
Japan Medical Association Certified Doctor
Get cancer treatment on the front line and participate in the latest clinical research on cancer treatment. From the cultivation of immune cells to the administration of clinical research, he participates in the whole process from the beginning to the end. It is a rare oncologist with training and clinical experience.
◎ Clinic address
〒108-0071 6F, LB Building, 3-14-4 Shirokanedai, Minato-ku, Tokyo
由東京大學醫科學研究所附屬醫院：緩和醫療・腫瘤科 土方康基科長進行癌症治療方案分析建議。 注意事項： 1.依照院方安排，看診時間會有所變動。 2.預約後取消將扣除行政費用150,000日幣返還。
30 min
198,000 Japanese yen
If you have any questions, please feel free to contact us through any of the methods below.
CONTACT US
TW contact only: ＋886-90-5563-717
JP For emergency contact: ＋81-80-4276-3930
JP Tel / Fax: ＋81-92 -984-3200
Mail: service@medicalsupporter.org
LINE@ ID: @medicalsupporter
LINE & WeChat & Skype: medicalsupporter
LINE@
LINE
